ArticleBMC geriatrics2026
Factors associated with family caregivers' attitudes toward deprescribing in long-term care facilities: a cross-sectional study in South Korea.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundDeprescribing has emerged as an important strategy for addressing polypharmacy among older adults in long-term care facilities (LTCFs). Family caregivers often play a key role in medication-related decision-making, yet factors associated with caregivers' attitudes toward deprescribing remain insufficiently understood. This study aimed to identify the factors associated with caregivers' attitudes toward deprescribing among residents of LTCFs in South Korea.
methodsA cross-sectional online survey was conducted with 973 family caregivers of residents in LTCFs. Attitudes toward deprescribing were assessed using the Korean version of the revised Patients' Attitudes Towards Deprescribing questionnaire (K-rPATD). Multiple linear regression models examined the associations of 16 measured predictors, represented by 18 regression terms, with four K-rPATD subscale scores and two global items, entered simultaneously. Unadjusted and Benjamini-Hochberg false discovery rate (FDR)-adjusted p values were computed for all 108 coefficients.
resultsOf the 973 caregivers included, 56.0% were male, 88.0% had a college education or higher, and 73.0% reported dual-track prescriptions. Among the K-rPATD subscales, involvement showed the highest mean score (3.63 ± 0.61), followed by burden (3.61 ± 0.72) and concerns about stopping (3.33 ± 0.64), whereas the reverse-scored appropriateness subscale had the lowest mean (2.52 ± 0.68). Residents took an average of 5.6 ± 3.5 medications, and 16.3% had experienced adverse drug events. After FDR correction, eight associations remained significant: adverse drug events with higher burden and concerns about stopping and lower appropriateness; medication cost with higher burden and concerns about stopping; number of medications with higher burden; and number of chronic conditions with higher concerns about stopping and involvement. All other nominally significant associations did not survive FDR correction and are considered exploratory.
conclusionsAfter correction for multiple comparisons, family caregivers' attitudes toward deprescribing were associated with the resident's medication-related circumstances - adverse drug events, medication cost, number of medications, and number of chronic conditions - rather than with caregivers' own sociodemographic characteristics. These cross-sectional findings are hypothesis-generating, but they help identify the family caregivers with whom deprescribing is most likely to be a relevant topic of discussion.
Indexed as
Identifiers
42850595What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.